EUVIMEDEUVIMED entdecken
Crossref

Therapeutic plasma exchange combined with ribavirin to rescue critical SFTS patients

Xuezhen Song, Xiaojun Xu, Xiaoning Ren, Xiaoxuan Ruan, Jinshuang Bo iD

Journal of Clinical Apheresis · 2024

DOI: 10.1002/jca.22131 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Apheresis, 2024. Verfasst von Xuezhen Song und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Blood Transfusion, Weihai Municipal Hospital, Cheeloo College of Medicine, Shandong University, Weihai, China. Hauptthemen laut MEDLINE: Ribavirin, Plasma Exchange, Critical Illness, Severe Fever with Thrombocytopenia Syndrome. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 15 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Severe fever with thrombocytopenia syndrome (SFTS) is a zoonotic infectious disease caused by the severe fever with thrombocytopenia syndrome virus (SFTSV). Endemic in East Asia, SFTS is characterized by an exceptionally high mortality rate. Presently, there is no established treatment for SFTS, particularly for patients in critical condition. In this study, we collected and analyzed laboratory and clinical data from 92 critically ill patients with SFTS treated at Weihai Municipal Hospital between 2019 and 2022. We hope that our study will provide some hints for the treatment of critically ill patients with SFTS.

Methods

A total of 92 critically ill patients with SFTS were included in this study. Of these patients, 45 received treatment with therapeutic plasma exchange (TPE) and ribavirin (referred to as the TPE group), while the remaining patients received only ribavirin (referred to as the non‐TPE group). Clinical and laboratory parameters were analyzed retrospectively.

Results

The results showed significant improvements in multiple laboratory parameters following treatment with TPE and ribavirin, including white blood cell and neutrophil count, lactate dehydrogenase, creatine kinase isoenzyme‐MB, prothrombin time, activated partial thromboplastin time, D‐Dimer, serum sodium and copies of virus genomes. The combination of TPE with ribavirin demonstrated a significant reduction in mortality rates, with a mortality rate of 20.0% in the TPE group compared to 40.4% in the non‐TPE group ( P = 0.033).

Conclusions

Our findings suggest that critically ill patients with SFTS who received TPE and ribavirin experienced improvements in both clinical and laboratory parameters. These results indicate that TPE combined with ribavirin may represent a promising novel therapeutic approach for managing critically ill patients with SFTS. However, comparative studies of large sample size or randomized clinical trials are warranted to confirm the effectiveness of this combination therapy in the treatment of severe SFTS cases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RibavirinPlasma ExchangeCritical IllnessSevere Fever with Thrombocytopenia SyndromeHumansMaleFemaleMiddle AgedRetrospective StudiesAgedAntiviral AgentsAdultCombined Modality Therapy

Stichwörter der Autor:innen

critically ill patientsplasma exchangeribavirinsevere fever with thrombocytopenia syndrome

Substanzen

RibavirinAntiviral Agents

Autor:innen und Institutionen

  • Department of Blood Transfusion, Weihai Municipal Hospital, Cheeloo College of Medicine, Shandong University, Weihai, China.

ORCID-Profile: Jinshuang Bo

Zitieren

APA

Song, X., Xu, X., Ren, X., Ruan, X., & Bo, J. (2024). Therapeutic plasma exchange combined with ribavirin to rescue critical SFTS patients. Journal of Clinical Apheresis. https://doi.org/10.1002/jca.22131

Vancouver

Song X, Xu X, Ren X, Ruan X, Bo J. Therapeutic plasma exchange combined with ribavirin to rescue critical SFTS patients. Journal of Clinical Apheresis. 2024. doi:10.1002/jca.22131

BibTeX
@article{Song2024,
  author = {Song, Xuezhen and Xu, Xiaojun and Ren, Xiaoning and Ruan, Xiaoxuan and Bo, Jinshuang},
  title = {Therapeutic plasma exchange combined with ribavirin to rescue critical SFTS patients},
  journal = {Journal of Clinical Apheresis},
  year = {2024},
  doi = {10.1002/jca.22131}
}
Kostenlos starten →